Scope Fluidics SA

Chart & Performance

D1W1MN

P/E

—

P/S

3,325.63

EPS

—

Div Yield, %

—

Shrs. gr., 5y

1.54%

Rev. gr., 5y

195.27%

Revenues

100k

-23.66%

Net income

-46m

CFO

-42m

L+68.46%

Dividend

Mar 24, 202385.57 PLN/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Scope Fluidics S.A. is a biotechnology firm dedicated to conceiving and advancing initiatives that harness microfluidic technologies within medical diagnostics and the broader healthcare landscape. Among its key offerings is BacterOMIC, a specialized system for conducting antibiotic susceptibility testing. This enterprise, established in 2010, conducts its operations from Warsaw, Poland.

URL

https://scopefluidics.com/

IPO date

Aug 16, 2017

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title PLN in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title PLN in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT